Venture Capital Investors

Enavate Sciences

Enavate Sciences is a VC investing group that funds select companies.

Venture Investor Overview

Contact Information

Background Information

Overview

Enavate Sciences is committed to invest in and support the strategic growth of innovative therapeutic and enabling technology companies that have the potential to transform patient care and improve quality of life. We consider a broad range of therapeutic areas being developed at both pre-clinical and clinical stage companies, prioritizing growth potential and areas of unmet medical need.

Profile

Social Media

Company News

Facebook

YouTube

Last Transaction

3/7/2024

Transaction History

Our records indicate that Enavate Sciences invested in the VC transactions listed below. Dollar amounts are for the entire raise, which may include other investors.

Investor Contacts

Title

Name

Email & Social

Chief Executive Officer

James Boylan

        

Vice President

Robert Glassman

        

Chairman

Jim Momtazee

        

Founding Partner

Neel Varshney

        

Funds

No fund closings have been recorded for this company.

Portfolio Companies

Enavate Sciences has invested in the companies below, according to our database records. If we are missing a portfolio company, please let us know.

Browse more venture capital investors:

Enabling Technology Fund | EnBW New Ventures

Share this article

About Our Venture Capital Investor Database

This VC firm profile is powered by VentureDeal.com, a leading provider of venture capital transaction data.

Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary